Valeant sells low-selling 'female viagra' to former owners

Discussion in 'Valeant Pharmaceuticals' started by RobertPhillips900, Nov 7, 2017 at 2:16 PM.

Tags:
  1. #1 RobertPhillips900, Nov 7, 2017 at 2:16 PM
    RobertPhillips900

    RobertPhillips900 new user

    Joined:
    Aug 29, 2016
    Messages:
    51
    Likes Received:
    0
    Valeant said it will sell Sprout, the subsidiary that produces Addyi-the female libido pill, to a former shareholder of Sprout in exchange for a 6% royalty on global sales of Addyi. The sale is expected to close before the end of 2017. Addyi is the only approved and commercialized product of Sprout. http://alph.st/b0896dd5
     
    Quote

  2. #2 anonymous, Nov 7, 2017 at 2:45 PM
    anonymous

    anonymous Guest

    What’s happening with sales force?
     
    Quote
  3. #3 anonymous, Nov 7, 2017 at 3:21 PM
    anonymous

    anonymous Guest

    What will happen to sales force?
     
    Quote
  4. #4 anonymous, Nov 8, 2017 at 6:52 AM
    anonymous

    anonymous Guest

    Quote
  5. #5 anonymous, Nov 8, 2017 at 9:03 AM
    anonymous

    anonymous Guest

    The sales force is being let go.
     
    Quote
  6. #6 anonymous, Nov 9, 2017 at 10:52 AM
    anonymous

    anonymous Guest

    Are they giving the sales reps a severance package?
     
    Quote
  7. #7 anonymous, Nov 9, 2017 at 11:04 AM
    anonymous

    anonymous Guest

     
    Quote
  8. #8 anonymous, Nov 9, 2017 at 11:06 AM
    anonymous

    anonymous Guest

    Why would you ask a dumb question like that?
     
    Quote
  9. #9 anonymous, Nov 17, 2017 at 4:15 PM
    anonymous

    anonymous Guest

    I think they're giving a severance of maybe 2 weeks to a month. If you sign it you waive all rights of being involved in any litigation against Valeant in the future. Read the severance carefully. Valeant is known to pay off employees to not come after them legally.
     
    Quote
  10. #10 anonymous, Nov 17, 2017 at 7:44 PM
    anonymous

    anonymous Guest

    They all do that. Boilerplate agreements.
     
    Quote
Reply to Thread